Status:
COMPLETED
Prevention and Screening Towards Elimination of Cervical Cancer
Lead Sponsor:
University Medical Center Groningen
Collaborating Sponsors:
Trnavska Universita v Trnavě
Uganda Cancer Institute
Conditions:
HPV Infection
Cervix Cancer
Eligibility:
FEMALE
30-60 years
Phase:
NA
Brief Summary
The research project applies the protocol of the World Health Organisation for screening of cervical cancer, with testing of hrHPV as first screening, followed by Visual Inspection of the cervix with ...
Detailed Description
The project performs community sensitisation and mobilisation in dedicated geographical areas and populations, to inform women and relatives about the importance of screening for cervical cancer. To ...
Eligibility Criteria
Inclusion
- Female in eligible age group
- Ability to give informed consent and participate in study
Exclusion
- Clinical signs of cervical carcinoma
- Menstruation or other vaginal blood loss
Key Trial Info
Start Date :
September 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2024
Estimated Enrollment :
30000 Patients enrolled
Trial Details
Trial ID
NCT05234112
Start Date
September 15 2022
End Date
January 31 2024
Last Update
February 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mpasana
Kakumiro, Uganda